Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Recruiting N/A Interventional Study
Opioid-use Disorder Cocaine Use Disorder Opioid Use Cocaine Use Substance Use Methamphetamine Abuse Methamphetamine-dependence
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
600 (estimated)
Sponsor
Wake Forest University Health Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Combatting the rise of the opioid epidemic is a central challenge of U.S. health care policy. A promising approach for improving welfare and decreasing medical costs of people with substance abuse disorders is offering incentive payments for healthy behaviors. This approach, broadly known as "contingency management" in the medical literature, has repeatedly shown to be effective in treating substa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age at least 18 years old; * Meet DSM-5 OUD, CoUD, or MUD criteria as evidenced by an OUD CPT code F11\* (opioid related disorders), a CoUD CPT code F14\* (cocaine related disorders), a MUD CPT code F15.1/F15.2 or other clinical notes indicating illicit opioid/cocaine/methamph…
Contacts

Kevin Petranu

414-293-9736

kevin.petranu@aah.org

CONTACT

Mercedes Robaina, PhD

813-352-9229

mercedes.robaina@aah.org

CONTACT